The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome

NCT01989000 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Gadobutrol
DRUG: [F-18]HX4
DRUG: Gemcitabine
RADIATION: Radiotherapy
PROCEDURE: Pancreaticoduodenectomy

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborators

[object Object]
[object Object]